Cumberland Pharmaceuticals (CPIX) Reports Q2 EPS of $0.04

Cumberland Pharmaceuticals (NASDAQ: CPIX) reported Q2 EPS of $0.04, versus $0.09 reported last year. Revenue for the quarter came in at $7.4 million, versus $8.9 million reported last year.

For earnings history and earnings-related data on Cumberland Pharmaceuticals (CPIX) click here.

You May Also Be Interested In

• Ennis (EBF) Reports In-Line Q1 EPS
• Evercore ISI Starts Credo Tech (CRDO) at Outperform
• CRH agrees to buy Arcosa in $8.5B all-cash deal